Opportunity ID: 309556

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-19-001
Funding Opportunity Title: Natural History Studies Addressing Unmet Needs of Rare Diseases: Orphan Products Research Project Grant (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Oct 12, 2018
Last Updated Date: Oct 15, 2018
Original Closing Date for Applications: Jan 10, 2019
Current Closing Date for Applications: Jan 10, 2019
Archive Date: Feb 09, 2019
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
State governments
Special district governments
Independent school districts
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Additional Information on Eligibility:

Additional Information

Agency Name: Food and Drug Administration
Description: The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development through the characterization of the natural history of rare diseases/conditions with unmet needs.
Through the support of efficient and innovative natural history studies, FDA expects to address critical knowledge gaps, to remove major barrier(s) to progress in the field, to exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and to inform current or future product development including the design of clinical trial(s) and to ultimately inform the development of medical products that meet patient needs. 
Link to Additional Information: Full application announcement
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Daniel Lukash

Grants Management Specialist

Phone 240-402-7596
Email:daniel.lukash@fda.hhs.gov

Version History

Version Modification Description Updated Date
Corrected "Funding Instrument Type" to be – grant Oct 15, 2018
Revised incorrect entry for expected number of award. The expected number is 5 Oct 15, 2018
Oct 12, 2018

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-19-001
Funding Opportunity Title: Natural History Studies Addressing Unmet Needs of Rare Diseases: Orphan Products Research Project Grant (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Oct 12, 2018
Last Updated Date: Oct 15, 2018
Original Closing Date for Applications: Jan 10, 2019
Current Closing Date for Applications: Jan 10, 2019
Archive Date: Feb 09, 2019
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
State governments
Special district governments
Independent school districts
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Additional Information on Eligibility:

Additional Information

Agency Name: Food and Drug Administration
Description: The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development through the characterization of the natural history of rare diseases/conditions with unmet needs.
Through the support of efficient and innovative natural history studies, FDA expects to address critical knowledge gaps, to remove major barrier(s) to progress in the field, to exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and to inform current or future product development including the design of clinical trial(s) and to ultimately inform the development of medical products that meet patient needs. 
Link to Additional Information: Full application announcement
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Daniel Lukash

Grants Management Specialist

Phone 240-402-7596
Email:daniel.lukash@fda.hhs.gov

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-19-001
Funding Opportunity Title: Natural History Studies Addressing Unmet Needs of Rare Diseases: Orphan Products Research Project Grant (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Oct 15, 2018
Last Updated Date: Oct 12, 2018
Original Closing Date for Applications:
Current Closing Date for Applications: Jan 10, 2019
Archive Date: Feb 09, 2019
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
State governments
Private institutions of higher education
Special district governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Public and State controlled institutions of higher education
Small businesses
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility:

Additional Information

Agency Name: Food and Drug Administration
Description: The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development through the characterization of the natural history of rare diseases/conditions with unmet needs.
Through the support of efficient and innovative natural history studies, FDA expects to address critical knowledge gaps, to remove major barrier(s) to progress in the field, to exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and to inform current or future product development including the design of clinical trial(s) and to ultimately inform the development of medical products that meet patient needs. 
Link to Additional Information: Full application announcement
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Daniel Lukash

Grants Management Specialist

Phone 240-402-7596
Email:daniel.lukash@fda.hhs.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-19-001
Funding Opportunity Title: Natural History Studies Addressing Unmet Needs of Rare Diseases: Orphan Products Research Project Grant (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards: 50
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 12, 2018
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Jan 10, 2019
Archive Date: Feb 09, 2019
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
State governments
Private institutions of higher education
Special district governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Public and State controlled institutions of higher education
Small businesses
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility:

Additional Information

Agency Name: Food and Drug Administration
Description: The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development through the characterization of the natural history of rare diseases/conditions with unmet needs.
Through the support of efficient and innovative natural history studies, FDA expects to address critical knowledge gaps, to remove major barrier(s) to progress in the field, to exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and to inform current or future product development including the design of clinical trial(s) and to ultimately inform the development of medical products that meet patient needs. 
Link to Additional Information: Full application announcement
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Daniel Lukash

Grants Management Specialist

Phone 240-402-7596
Email:daniel.lukash@fda.hhs.gov

Related Documents

Packages

Agency Contact Information: Daniel Lukash
Grants Management Specialist
Phone 240-402-7596
Email: daniel.lukash@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 RFA-FD-19-001 Form E PKG00245546 Nov 10, 2018 Jan 10, 2019 View

Package 1

Mandatory forms

309556 RR_SF424_2_0-2.0.pdf

309556 PHS398_CoverPageSupplement_4_0-4.0.pdf

309556 RR_OtherProjectInfo_1_4-1.4.pdf

309556 PerformanceSite_2_0-2.0.pdf

309556 RR_KeyPersonExpanded_2_0-2.0.pdf

309556 RR_Budget_1_4-1.4.pdf

309556 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

309556 RR_SubawardBudget30_1_4-1.4.pdf

309556 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T08:44:50-05:00

Share This Post, Choose Your Platform!

About the Author: